Finance

Lists
NRXP:NASDAQ
NRX Pharmaceuticals Inc
$ 2.90
-1.36%
(-0.040) 1D
$ 2.90
0.00% (0.00)
Pre-market
Closed: 10-р сарын 7, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRXP...
Open
$ 2.88
High
$ 2.93
Low
$ 2.87
Mkt. cap
125.56 сая
Avg. vol.
659.81 мян
Volume
1.01 мян
52-wk high
$ 5.06
52-wk low
$ 1.62
EPS
-$ 0.74
Beta
2.08
Shares outstanding
43.30 сая
No. of employees
29
Open
$ 2.88
High
$ 2.93
Low
$ 2.87
Mkt. cap
125.56 сая
Avg. vol.
659.81 мян
Volume
1.01 мян
52-wk high
$ 5.06
52-wk low
$ 1.62
EPS
-$ 0.74
Beta
2.08
Shares outstanding
43.30 сая
No. of employees
29
News stories
From web sources and news partners
About NRX Pharmaceuticals Inc
CEO-
Employees29
Founded2015
HeadquartersWilmington, Делавар, Америкийн Нэгдсэн Улс
SectorPharmaceutical industry
Websitenrxpharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to NRXP in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NRXP in the last 3 months.
Highest
Current $ 2.90
$ 50.00 (+1,624.14%)
Average
$ 35.00 (+1,106.90%)
Lowest
$ 10.00 (+244.83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
$ 50.00
+1,624.1%
09/30/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$ 45.00
+1,451.7%
09/21/2026
Thomas Shrader
BTIG
Buy
Maintained
$ 10.00
+244.8%
09/14/2026
Elemer Piros
Lucid Capital
Buy
Initiated
$ 49.00
+1,589.7%
05/13/2026
Jason Kolbert
D. Boral Capital
Buy
Maintained
$ 34.00
+1,072.4%
04/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
242.00 мян
983.00 мян
1.07 сая
1.10 сая
Cost of goods sold
97.00 мян
408.00 мян
631.00 мян
675.00 мян
Cost of revenue
97.00 мян
408.00 мян
631.00 мян
675.00 мян
Research and development expenses
1.43 сая
558.00 мян
1.31 сая
2.12 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.81 сая
4.57 сая
3.81 сая
4.74 сая
Operating expense
4.26 сая
5.17 сая
5.18 сая
6.93 сая
Total operating expenses
4.36 сая
5.58 сая
5.82 сая
7.60 сая
Operating income
-4.12 сая
-4.59 сая
-4.75 сая
-6.50 сая
Other non operating income
-366.00 мян
1.59 сая
3.54 сая
-9.78 сая
EBT including unusual items
-5.89 сая
360.00 мян
-1.43 сая
-16.52 сая
EBT excluding unusual items
-4.48 сая
-3.67 сая
-1.44 сая
-16.52 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.89 сая
360.00 мян
-1.43 сая
-16.52 сая
Net profit margin
-2,433.88%
36.62%
-133.90%
-1,500.45%
Earnings per share
-0.51
0.18
-0.04
-0.24
Interest and investment income
2.00 мян
4.00 мян
5.00 мян
6.00 мян
Interest expense
-
-671.00 мян
-233.00 мян
-240.00 мян
Net interest expenses
2.00 мян
-667.00 мян
-228.00 мян
-234.00 мян
Depreciation and amortization charges
26.00 мян
42.00 мян
63.00 мян
66.00 мян
EBITDA
-4.11 сая
-4.55 сая
-4.68 сая
-6.43 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс